Sugars |
|
|
58 |
31.08, 31.24, 31.33, 32.66 |
fructose, pentakis(TMS) |
63 |
32.84, 34.67 |
glucose,
pentakis(TMS) |
64 |
32.94 |
mannose, pentakis(TMS) |
88 |
30.06 |
xylose, tetrakis(TMS) |
Amino
Sugars |
62 |
32.36 |
glucosamine, tetrakis(TMS)a
|
62 |
33.29 |
glucosamine,
hexakis(TMS) |
65 |
33.74 |
fructosamine, hexakis(TMS)b
|
69 |
37.98, 38.17, 38.58, 39.31 |
aminohexopyranosid, hexakis(TMS)b
|
71 |
41.15, 41.47, 41.76, 41.88,
42.01, 42.50, 46.26, 46.69, 47.10, 48.39, 49.57, 49.76, 49.94 |
aminoglycosides of unknown constitutionb
|
73 |
47.56 |
di(glucopyranosyl)amine, octakis(TMS)b
|
Carboxylic Acids |
35 |
11.87 |
lactic acid, bis(TMS)a
|
36 |
12.30 |
glycolic acid, bis(TMS)a
|
37 |
14.01 |
oxalic acid, bis(TMS)
estera
|
38 |
14.28 |
3-hydroxypropanoic acid, bis(TMS)a
|
42 |
19.66 |
glyceric acid, tris(TMS)d
|
45 |
21.78 |
2,4-dihydroxybutyric
acid, tris(TMS)a
|
46 |
22.34 |
3,4-dihydroxybutyric acid, tris(TMS)a
|
49 |
25.21 |
erythronic acid, tetrakis(TMS)a
|
50 |
25.62 |
threonic acid,
tetrakis(TMS)a
|
53 |
27.79 |
2-deoxypentonic acid, tetrakis(TMS)d
|
54 |
27.96 |
3-deoxypentonic acid, tetrakis(TMS)d
|
56 |
30.26 |
ribonic
acid, pentakis(TMS)a
|
57 |
30.61 |
arabinoic acid, pentakis(TMS)a
|
89 |
30.44 |
xylonic acid, pentakis(TMS)a
|
60 |
32.14 |
2-deoxyhexonic
acid, pentakis(TMS)b
|
61 |
32.25 |
3-deoxyhexonic acid, pentakis(TMS)d
|
66 |
34.37,
35.06 |
hexonic acid, hexakis(TMS)d
|
Carboxylic Acid Amides |
86 |
7.16 |
acetic amidea
|
6 |
15.03 |
lactamide, bis(TMS)a
|
7 |
15.63 |
glycolamide, bis(TMS)a (coeluting
with pyrazinylmethanol) |
10 |
17.25 |
urea, N,N′-bis(TMS)a
|
32 |
8.61,
11.00 |
bis(TMS) formamide (two peaks)a
|
33 |
8.95 |
carbodiimide, N,N′-bis(TMS) (from urea)a
|
34 |
11.00, 15.95 |
carbamate, bis(TMS) and -tris(TMS)a
|
39 |
17.51 |
oxamic
acid, bis(TMS)b
|
Amino
Carboxylic Acids |
41 |
13.56, 18.83 |
glycine, bis(TMS) and -tris(TMS)a
|
47 |
23.20 |
2-aminomalonic acid, tris(TMS)d
|
74 |
13.07 |
alanine, bis(TMS)a
|
75 |
17.50,
20.43 |
serine, bisTMS and −trisTMSa
|
52 |
21.59 |
β-alanine, tris(TMS)d
|
1H-Imidazoles |
2 |
12.87 |
1H-imidazole
(TMS)a
|
5 |
14.68 |
4-methyl-1H-imidazole
(TMS)a
|
43 |
20.90 |
4-hydroxymethyl-1H-imidazole,
bis(TMS)a
|
55 |
28.79 |
4-(1,2-dihydroxyethyl)-1H-imidazole, tris(TMS)b
|
68 |
35.92 |
4-(d-arabino-tetrahydroxybutyl)-1H-imidazole, pentakis(TMS)a
|
77 |
36.22 |
2-acetyl-4-(tetrahydroxybutyl)-1H-imidazole,
pentakis(TMSb
|
90 |
31.87 |
4(5)-(trihydroxypropyl)-1H-imidazole, tris-O-(TMS)b
|
Pyridines |
4 |
13.90 |
3-hydroxypyridine,
TMSa
|
20 |
24.60 |
2-(hydroxymethyl)-pyridin-5-ol, bis(TMS)b
|
Pyrazines |
1 |
11.85 |
2-pyrazinol, TMSa
|
3 |
13.02 |
2-hydroxy-5-methylpyrazine, TMS or isomerb
|
7 |
15.61 |
2-pyrazinylmethanol, TMSa
|
8 |
15.83 |
2-hydroxy-3-methylpyrazine,
TMS or isomerb
|
12 |
17.94 |
2-hydroxymethyl-6-methylpyrazine,
TMSa
|
18 |
23.45 |
2-(dihydroxyethyl)pyrazine, bis(TMS)c
|
21 |
24.77,
25.10, 25.36, 25.83, xylose only: 24.23 |
2-(dihydroxyethyl)-5-methyl-pyrazine,
bis(TMS)b and isomers |
22 |
26.34, 26.57 |
2,5a- and 2,6b-bis(hydroxymethyl)pyrazine,
bis(TMS) |
23 |
31.76 |
2-(dihydroxyethyl)-5(hydroxymethyl)pyrazine, tris(TMS)b
|
24 |
33.07 |
2-(tetrahydroxybutyl)pyrazine, tetrakis(TMS)b
|
25 |
33.45, 33.60, 33.75,
33.90 |
2-(tetrahydroxybutyl)-5-methyl-pyrazine, tetrakis(TMS)b and isomers |
28 |
28.76, 28.91 |
2-(trihydroxypropyl)pyrazine, tris(TMS)b, 2 isomers |
29 |
29.48, 29.58, 29.76, 29.86 |
2-(trihydroxybutyl)-5-methylpyrazine,
tris(TMS) and isomersb
|
30 |
34.90, 35.50 |
2-(trihydroxybutyl)-5-(hydroxymethyl)pyrazine,
tetrakis(TMS)
and isomersb
|
78 |
36.10, 36.34 |
2-hydroxy-5 (and 6)-(tetrahydroxybutyl)pyrazine,
pentakis(TMS)b
|
79 |
37.96, 38.36 |
2-(hydroxymethyl)-5 (and
6)-(tetrahydroxybutyl)pyrazine, pentakis(TMS)b
|
80 |
39.24, 39.79 |
2-(2-hydroxyethyl)-5 (and 6)-tetrahydroxybutyl pyrazine, pentakis(TMS)b
|
81 |
41.23,
41.58 |
2-(dihydroxyethyl)-5 (and 6)-tetrahydroxybutyl
pyrazine, hexakis(TMS)b
|
82 |
42.92, 43.37 |
2-(2,3-dihydroxypropyl)-5
(and 6)-tetrahydroxybutyl pyrazine,
hexakis(TMS)b
|
83 |
43.92, 44.40 |
2-(trihydroxypropyl)-5
(and 6)-tetrahydroxybutyl pyrazine,
hexakis(TMS)b
|
84 |
46.03, 46.08 |
2,5- and 2,6-deoxyfructosazine,
heptakis(TMS)b
|
85 |
46.87, 7.11, 48.07,48.28 |
2,5- and
2,6-fructosazine and diastereomers, octakis(TMS)b
|
87 |
29.51, 29.81 |
2-methyl-5 (and 6)-(trihydroxypropyl)pyrazine, tetrakis(TMS)b
|
93 |
34.77,
34.83, 35.23, 35.44 |
2-hydroxymethyl-5(and 6)-(trihydroxypropyl)
pyrazine, tetrakis
(TMS)b
|
94 |
35.96, 36.08, 36.54, 36.79, 36.95, 37.80 |
2-(hydroxyethyl)-5-(trihydroxypropyl)pyrazine,
tetrakis(TMS)
and isomersb
|
95 |
38.15, 39.01 |
2-dihydroxyethyl-5 (and 6)-trihydroxybutyl
pyrazine, pentakis
TMSb
|
96 |
39.88, 40.89 |
2-(dihydroxypropyl)-5 (and 6)-trihydroxypropyl
pyrazine, hexakis(TMS)b
|
97 |
40.94, 41.10, 41.55, 41.91 |
2,5-
and 2,6-trihydroxypropyl pyrazine, hexakis(TMS)b
|
Others and Unknown |
11 |
17.75 |
DMAP (catalyst)a
|
13 |
18.66 |
2-methylquinoxaline (added)a
|
31 |
8.44 |
trifluoromethyl-bis-(trimethylsilyl)methyl
ketone (silylation
artifact)d
|
40 |
18.09 |
phosphate, tris(TMS) ester (internal standard)a
|
51 |
27.05 |
M+ = 272 |
59 |
32.00 |
M+ = 525 |
70 |
40.50 |
phenyl-α-glucopyranosid
(internal standard)a
|
9 |
16.69 |
M+ = 196 |
14 |
19.40, 19.52 |
M+ = 180 |
15 |
20.08–20.70 |
mixture of low abundance
compounds |
16 |
22.27 |
M+ = 321 |
17 |
23.01 |
M+ = 270 |
19 |
23.84 |
M+ = 331 |
26, 27 |
21.18, 22.03 |
M+ = 256 |
44 |
21.09 |
M+ = 249 |
45 |
21.59 |
M+ = 244 |
48 |
21.99 |
M+ = 248 |
51 |
23.22 |
M+ = 242 |
67 |
27.05 |
M+ = 272 |
72 |
34.49 |
M+ = 493 |
76 |
45.88 |
M+ = 502 |
91 |
35.13 |
M+ = 459 |
92 |
33.21,
33.70 |
M+ = 400 |
98 |
31.59, 31.70 |
M+ = 414 |